Atlantic Edge Private Wealth Management LLC decreased its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 13.5% during the 4th quarter, HoldingsChannel reports. The fund owned 8,961 shares of the pharmacy operator’s stock after selling 1,398 shares during the quarter. Atlantic Edge Private Wealth Management LLC’s holdings in CVS Health were worth $402,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of CVS. AMF Tjanstepension AB boosted its holdings in CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after purchasing an additional 34,198 shares in the last quarter. Exchange Traded Concepts LLC raised its stake in shares of CVS Health by 61.9% during the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock worth $934,000 after purchasing an additional 5,679 shares during the last quarter. Sound Income Strategies LLC raised its stake in shares of CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock worth $151,000 after purchasing an additional 162 shares during the last quarter. Orca Investment Management LLC raised its position in CVS Health by 30.0% in the third quarter. Orca Investment Management LLC now owns 40,475 shares of the pharmacy operator’s stock worth $2,545,000 after acquiring an additional 9,341 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its stake in CVS Health by 32.5% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 7,805 shares of the pharmacy operator’s stock worth $491,000 after buying an additional 1,914 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Stock Up 0.4 %
Shares of CVS opened at $54.24 on Tuesday. The stock has a market capitalization of $68.26 billion, a price-to-earnings ratio of 13.77, a PEG ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The stock has a fifty day moving average of $50.79 and a 200-day moving average of $55.98.
CVS Health Announces Dividend
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. TD Cowen lifted their price objective on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Mizuho decreased their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Finally, Truist Financial dropped their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.
Get Our Latest Analysis on CVS
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Using the MarketBeat Stock Split Calculator
- Monday.com Stock Could Soar to New Highs—Here’s How
- The 3 Best Fintech Stocks to Buy Now
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Why is the Ex-Dividend Date Significant to Investors?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.